Found 5 matching trials
A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment PHASE3 The study is being conducted to evaluate the efficacy, and safety of HRS-70...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases PHASE2 Background:KRAS mutations are the most common genetic alterations in colore...
Show More Location
Second Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer PHASE2 This study investigated the efficacy and safety of Tunlametinib Combination...
Show More Location
Multiple Locations
Learn More & Join Trial
Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC PHASE2 This is an exploratory study evaluating the efficacy and safety of neoadjuv...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab (AK-112) in First-line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer Patients With KRAS G12C Mutation PHASE2 A multicenter, single-arm Phase II study to evaluate the efficacy and safet...
Show More Location
Multiple Locations
Learn More & Join Trial